Tudóstér: Majoros László publikációi

PDF
-
szűkítés
feltöltött közlemény: 115 Open Access: 50
2024
  1. Jakab, Á., Kovács, F., Balla, N., Nagy-Köteles, C., Ragyák, Á., Nagy, F., Borman, A., Majoros, L., Kovács, R.: Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
    Microbiol. Spectr. [Epub ahead of print]2024.
    Folyóirat-mutatók:
    Q2 Cell Biology (2022)
    Q1 Ecology (2022)
    Q2 Genetics (2022)
    Q1 Immunology and Microbiology (miscellaneous) (2022)
    Q1 Infectious Diseases (2022)
    Q1 Microbiology (medical) (2022)
    Q1 Physiology (2022)
  2. Domán, M., Kaszab, E., Laczkó, L., Bali, K., Makrai, L., Kovács, R., Majoros, L., Bányai, K.: Genomic epidemiology of antifungal resistance in human and avian isolates of Candida albicans: a pilot study from the One Health perspective.
    Front. Vet. Sci. 11 1-7, 2024.
    Folyóirat-mutatók:
    D1 Veterinary (miscellaneous) (2022)
2023
  1. Kovács, F., Balla, N., Tóth, Z., Jakab, Á., Majoros, L., Kovács, R.: Impact of n-acyl-homoserine lactone, quorum sensing molecule, on candida auris isolates.
    Acta Microbiol. Immunol. Hung. 70 (Supplement), 30-31, 2023.
  2. Adnan, A., Borman, A., Tóth, Z., Forgács, L., Kovács, R., Balázsi, D., Balázs, B., Udvarhelyi, G., Kardos, G., Majoros, L.: In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades.
    Pharmaceutics. 15 (5), 1-16, 2023.
    Folyóirat-mutatók:
    Q1 Pharmaceutical Science (2022)
  3. Balla, N., Kovács, F., Tóth, Z., Jakab, Á., Majoros, L., Kovács, R.: The effect of caspofungin in combination with posaconazole against echinocandin susceptible and resistant candida auris isolates.
    Acta Microbiol. Immunol. Hung. 70 (Supplement), 6-7, 2023.
  4. Tóth, Z., Bozó, A., Kovács, R., Balogh, B., Balázs, B., Forgács, L., Kelentey, B., Majoros, L.: The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
    Mycopathologia. 188 (1-2), 111-118, 2023.
    Folyóirat-mutatók:
    Q1 Agronomy and Crop Science (2022)
    Q2 Applied Microbiology and Biotechnology (2022)
    Q2 Microbiology (2022)
    Q1 Plant Science (2022)
    D1 Veterinary (miscellaneous) (2022)
  5. Balla, N., Jakab, Á., Kovács, F., Ragyák, Á., Tóth, Z., Balázsi, D., Forgács, L., Bozó, A., Al Refai, F., Borman, A., Majoros, L., Kovács, R.: Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol.
    AMB Express. 13 (1), 1-10, 2023.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology (2022)
    Q2 Biophysics (2022)
  6. Kovács, R., Kovács, F., Balla, N., Ragyák, Á., Sajtos, Z., Majoros, L., Jakab, Á.: Transcriptional changes and related physiological effect caused by tyrosol exposure in Candida auris.
    In: ECFG16 abstractbook, PCO Tyrol Congress, Innsbruck, 425-426, 2023.
  7. Kovács, R., Majoros, L., Stemler, J., Cornely, O., Salmanton-García, J.: Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.
    Therapeutic Advances in Infection. [Epub ahead of print]2023.
    Folyóirat-mutatók:
    Q1 Infectious Diseases (2022)
    Q1 Pharmacology (medical) (2022)
2022
  1. Kovács, R., Majoros, L.: Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?.
    Lett. Appl. Microbiol. 74 (6), 851-862, 2022.
    Folyóirat-mutatók:
    Q3 Applied Microbiology and Biotechnology
  2. Nagy, J., Balázs, B., Benmazouz, I., Gyüre, P., Kövér, L., Kaszab, E., Bali, K., Lovas-Kiss, Á., Damjanova, I., Majoros, L., Tóth, Á., Bányai, K., Kardos, G.: Comparison of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates From Rooks (Corvus frugilegus) and Contemporary Human-Derived Strains: A One Health Perspective.
    Front. Microbiol. 12 1-9, 2022.
    Folyóirat-mutatók:
    Q1 Microbiology
    Q1 Microbiology (medical)
  3. Balázs, B., Tóth, Z., Nagy, J., Majoros, L., Tóth, Á., Kardos, G.: Faecal Carriage of Carbapenem-Resistant Acinetobacter baumannii: comparison to Clinical Isolates from the Same Period (2017-2019).
    Pathogens. 11 (9), 1-9, 2022.
    Folyóirat-mutatók:
    Q2 Immunology and Allergy
    Q2 Immunology and Microbiology (miscellaneous)
    Q2 Infectious Diseases
    Q2 Microbiology (medical)
    Q2 Molecular Biology
  4. Imre, A., Kovács, R., Tóth, Z., Majoros, L., Benkő, Z., Pfliegler, V., Pócsi, I.: Heme Oxygenase-1 (HMX1) Loss of Function Increases the In-Host Fitness of the Saccharomyces 'boulardii' Probiotic Yeast in a Mouse Fungemia Model.
    J. Fungi. 8 (5), 522, 2022.
    Folyóirat-mutatók:
    Q1 Ecology, Evolution, Behavior and Systematics
    Q2 Microbiology (medical)
    Q1 Plant Science
  5. Forgács, L., Borman, A., Kovács, R., Balázsi, D., Tóth, Z., Balázs, B., Chun-Ju, C., Kardos, G., Kovács, I., Majoros, L.: In Vivo Efficacy of Amphotericin B against Four Candida auris Clades.
    J. Fungi. 8 (5), 1-16, 2022.
    Folyóirat-mutatók:
    Q1 Ecology, Evolution, Behavior and Systematics
    Q2 Microbiology (medical)
    Q1 Plant Science
  6. Jakab, Á., Kovács, F., Balla, N., Tóth, Z., Ragyák, Á., Sajtos, Z., Csillag, K., Nagy-Köteles, C., Nemes, D., Bácskay, I., Pócsi, I., Majoros, L., Kovács, Á., Kovács, R.: Physiological and transcriptional profiling of surfactin exerted antifungal effect against Candida albicans.
    Biomed. Pharmacother. 152 1-10, 2022.
    Folyóirat-mutatók:
    Q1 Medicine (miscellaneous)
    Q1 Pharmacology
  7. Balla, N., Kovács, F., Balázs, B., Borman, A., Bozó, A., Jakab, Á., Tóth, Z., Kobaissi, O., Majoros, L., Kovács, R.: Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms.
    Antibiotics-Basel. 11 (11), 1-12, 2022.
    Folyóirat-mutatók:
    Q2 Biochemistry
    Q2 Infectious Diseases
    Q2 Microbiology
    Q2 Microbiology (medical)
    Q2 Pharmacology (medical)
    Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  8. Kovács, R., Balla, N., Kovács, F., Majoros, L., Jakab, Á.: Transcriptional response of Candida auris biofilms to farnesol and tyrosol treatment.
    In: Eurobiofilms abstractbook, [s.n.], Palma de Mallorca, 143, 2022.
  9. Imre, A., Kovács, R., Tóth, Z., Majoros, L., Benkő, Z., Pócsi, I., Pfliegler, V.: Variability of the probiotic yeast saccharomyces cerevisiae var. `BOULARDII` in genome, phenotype, and virulence.
    In: Biotechnology at the University of Debrecen - 2022 International Symposium : Abstarct Book, Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Environmental Management, Central Laboratory of Agricultural and Food Products, Debrecen, 38-39, 2022. ISBN: 9789634904687
2021
  1. Kovács, R., Tóth, Z., Locke, J., Forgács, L., Kardos, G., Nagy, F., Borman, A., Majoros, L.: Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.
    Microorganisms. 9 (4), 1-12, 2021.
    Folyóirat-mutatók:
    Q2 Microbiology
    Q2 Microbiology (medical)
    Q3 Virology
  2. Nagy, F., Tóth, Z., Váradi, G., Tóth, L., Forgács, L., Vadászi, K., Majoros, L., Galgóczy, L., Kovács, R.: Echinocandinok és a Neosartorya fischeri antifungális fehérje 2 (NFAP2) kombinációjának in vitro vizsgálata Candida auris biofilmek ellen.
    Acta Microbiol. Immunol. Hung. 68 28-29, 2021.
  3. Tóth, H., Buchholcz, G., Fésüs, A., Balázs, B., Nagy, J., Majoros, L., Szarka, K., Kardos, G.: Evolution of the Gram-Negative Antibiotic Resistance Spiral over Time: a Time-Series Analysis.
    Antibiotics-Basel. 10 (6), 1-10, 2021.
    Folyóirat-mutatók:
    Q2 Biochemistry
    Q2 Infectious Diseases
    Q2 Microbiology
    Q2 Microbiology (medical)
    Q2 Pharmacology (medical)
    Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  4. Nagy, F., Tóth, Z., Nyikos, F., Forgács, L., Jakab, Á., Borman, A., Majoros, L., Kovács, R.: In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
    Med. Mycol. 59 (10), 1015-1023, 2021.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q2 Medicine (miscellaneous)
    D1 Veterinary (miscellaneous)
  5. Domán, M., Makrai, L., Lengyel, G., Kovács, R., Majoros, L., Bányai, K.: Molecular Diversity and Genetic Relatedness of Candida albicans Isolates from Birds in Hungary.
    Mycopathologia. 186 (2), 237-244, 2021.
    Folyóirat-mutatók:
    Q2 Agronomy and Crop Science
    Q2 Applied Microbiology and Biotechnology
    Q3 Microbiology
    Q2 Plant Science
    Q1 Veterinary (miscellaneous)
  6. Kovács, R., Nagy, F., Tóth, Z., Forgács, L., Tóth, L., Váradi, G., Tóth, G., Vadászi, K., Borman, A., Majoros, L., Galgóczy, L.: The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
    Int. J. Mol. Sci. 22 (2), 1-14, 2021.
    Folyóirat-mutatók:
    Q2 Catalysis
    Q1 Computer Science Applications
    Q1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    Q1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  7. Balázs, B., Tóth, Z., Nagy, F., Kovács, R., Tóth, H., Nagy, J., Tóth, Á., Szarka, K., Majoros, L., Kardos, G.: The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.
    Antibiotics. 10 (2), 1-12, 2021.
    Folyóirat-mutatók:
    Q2 Biochemistry
    Q2 Infectious Diseases
    Q2 Microbiology
    Q2 Microbiology (medical)
    Q2 Pharmacology (medical)
    Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  8. Jakab, Á., Balla, N., Ragyák, Á., Nagy, F., Kovács, F., Sajtos, Z., Tóth, Z., Borman, A., Pócsi, I., Baranyai, E., Majoros, L., Kovács, R.: Transcriptional profiling of the Candida auris response to exogenous farnesol exposure.
    mSphere. 6 (5), 1-12, 2021.
    Folyóirat-mutatók:
    Q1 Microbiology
    Q2 Molecular Biology
  9. Kovács, R., Jakab, Á., Ragyák, Á., Sajtos, Z., Nagy, F., Baranyai, E., Pócsi, I., Majoros, L.: Transcriptomic approaches for the farnesol exposure of Candida auris.
    Acta Microbiol. Immunol. Hung. 68 85, 2021.
  10. Papp, Z., Borman, A., Forgács, L., Kovács, R., Tóth, Z., Chun-Ju, C., Kardos, G., Juhász, B., Szilvássy, J., Majoros, L.: Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades.
    Pathogens. 10 (8), 1-11, 2021.
    Folyóirat-mutatók:
    Q2 Immunology and Allergy
    Q2 Immunology and Microbiology (miscellaneous)
    Q2 Infectious Diseases
    Q2 Microbiology (medical)
    Q2 Molecular Biology
  11. Imre, A., Kovács, R., Pázmándi, K., Nemes, D., Jakab, Á., Fekete, T., Rácz, H., Dóczi, I., Bácskay, I., Gácser, A., Kovács, K., Majoros, L., Farkas, Z., Pócsi, I., Pfliegler, V.: Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (Saccharomyces 'boulardii').
    J. Fungi. 7 (9), 1-29, 2021.
    Folyóirat-mutatók:
    Q1 Ecology, Evolution, Behavior and Systematics
    Q2 Microbiology (medical)
    Q1 Plant Science
2020
  1. Nagy, M., Szemán-Nagy, G., Kiss, A., Nagy, Z., Tálas, L., Rácz, D., Majoros, L., Tóth, Z., Máthéné Szigeti, Z., Pócsi, I., Kéki, S.: Antifungal Activity of an Original Amino-Isocyanonaphthalene (ICAN) Compound Family: Promising Broad Spectrum Antifungals.
    Molecules. 25 (4), 1-12, 2020.
    Folyóirat-mutatók:
    Q2 Analytical Chemistry
    Q1 Chemistry (miscellaneous)
    Q2 Drug Discovery
    Q2 Medicine (miscellaneous)
    Q3 Molecular Medicine
    Q2 Organic Chemistry
    Q1 Pharmaceutical Science
    Q2 Physical and Theoretical Chemistry
  2. Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., Kovács, R.: Candida biofilm production is associated with higher mortality in patients with candidaemia.
    Mycoses. 63 (4), 352-360, 2020.
    Folyóirat-mutatók:
    Q1 Dermatology
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
  3. Forgács, L., Borman, A., Prépost, E., Tóth, Z., Kardos, G., Kovács, R., Székely, A., Nagy, F., Kovács, I., Majoros, L.: Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
    Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.
    Folyóirat-mutatók:
    D1 Drug Discovery
    Q1 Epidemiology
    Q1 Immunology
    D1 Infectious Diseases
    D1 Medicine (miscellaneous)
    Q1 Microbiology
    D1 Parasitology
    Q1 Virology
  4. Kovács, R., Majoros, L.: Fungal Quorum-Sensing Molecules: a Review of Their Antifungal Effect against Candida Biofilms.
    J. Fungi. 6 (3), 99, 2020.
    Folyóirat-mutatók:
    D1 Ecology, Evolution, Behavior and Systematics
    Q1 Microbiology (medical)
    D1 Plant Science
  5. Nagy, F., Vitális, E., Jakab, Á., Borman, A., Forgács, L., Tóth, Z., Majoros, L., Kovács, R.: In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
    Front. Microbiol. 11 1-12, 2020.
    Folyóirat-mutatók:
    Q1 Microbiology
    Q1 Microbiology (medical)
  6. Tóth, Z., Forgács, L., Kardos, T., Kovács, R., Locke, J., Kardos, G., Nagy, F., Borman, A., Adnan, A., Majoros, L.: Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
    J. Fungi. 6 (3), 1-9, 2020.
    Folyóirat-mutatók:
    D1 Ecology, Evolution, Behavior and Systematics
    Q1 Microbiology (medical)
    D1 Plant Science
2019
  1. Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Borman, A., Majoros, L.: Comparison of killing activity of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris in the presence and absence of serum.
    J. Fungi. 5 (95), 130-131, 2019.
  2. Prépost, E., Tóth, Z., Perlin, D., Gesztelyi, R., Kardos, G., Kovács, R., Nagy, F., Forgács, L., Majoros, L.: Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.
    Infect Drug Resist. 12 1805-1814, 2019.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Pharmacology
    Q2 Pharmacology (medical)
  3. Nagy, F., Tóth, Z., Daróczi, L., Székely, A., Borman, A., Majoros, L., Kovács, R.: Farnesol increases the activity of echinocandins against Candida auris biofilms.
    Med. Mycol. 58 (3), 404-407, 2019.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    D1 Veterinary (miscellaneous)
  4. Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., Kovács, R.: Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
    Med. Mycol. 57 (5), 573-581, 2019.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    D1 Veterinary (miscellaneous)
  5. Forgács, L., Tóth, Z., Locke, J., Nagy, F., Balázs, B., Prépost, E., Kardos, G., Kovács, R., Székely, A., Borman, A., Majoros, L.: Frequency of paradoxical and trailing effects with rezafungin, anidulafungin, caspofungin and micafungin against Candida species.
    J. Fungi. 5 (95), 131-132, 2019.
  6. Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Székely, A., Borman, A., Majoros, L.: In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
    J. Antimicrob. Chemother. 74 (12), 3505-3510, 2019.
    Folyóirat-mutatók:
    D1 Infectious Diseases
    D1 Microbiology (medical)
    D1 Pharmacology
    D1 Pharmacology (medical)
  7. Kovács, R., Holzknecht, J., Hargitai, Z., Papp, C., Farkas, A., Borics, A., Tóth, L., Váradi, G., Tóth, G., Kovács, I., Dubrac, S., Majoros, L., Marx, F., Galgóczy, L.: In vivo applicability of Neosartorya fischeri antifungal protein 2 (NFAP2) in treatment of vulvovaginal candidiasis.
    Antimicrob. Agents Chemother. 63 (2), 1-12, 2019.
    Folyóirat-mutatók:
    D1 Infectious Diseases
    D1 Pharmacology
    D1 Pharmacology (medical)
  8. Váradi, J., Hermenean, A., Gesztelyi, R., Jeney, V., Balogh, E., Majoros, L., Malanga, M., Fenyvesi, É., Szente, L., Bácskay, I., Vecsernyés, M., Fehér, P., Ujhelyi, Z., Vasvári, G., Árvai, I., Rusznyák, Á., Balta, C., Herman, H., Fenyvesi, F.: Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin.
    Biomolecules. 9 (10), 1-13, 2019.
    Folyóirat-mutatók:
    Q1 Biochemistry
    Q2 Molecular Biology
  9. Jakab, Á., Tóth, Z., Nagy, F., Nemes, D., Bácskay, I., Kardos, G., Emri, T., Pócsi, I., Majoros, L., Kovács, R.: Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.
    Appl. Environ. Microbiol. 85 (20), 1-12, 2019.
    Folyóirat-mutatók:
    D1 Applied Microbiology and Biotechnology
    Q1 Biotechnology
    D1 Ecology
    D1 Food Science
  10. Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Balázs, B., Majoros, L.: Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
    Lett. Appl. Microbiol. 69 (4), 271-278, 2019.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology
  11. Nagy, F., Tóth, Z., Forgács, L., Borman, A., Majoros, L., Balázs, B., Kovács, R.: The effect of farnesol on Candida auris biofilms, virulence and azole susceptibility.
    J. Fungi. 95 (5), 141-142, 2019.
  12. Kovács, R., Nagy, F., Tóth, Z., Majoros, L.: The effect of nikkomycin Z in combination with echinocandins against Candida albicans and Candida parapsilosis biofilms.
    Acta Microbiol. Immunol. Hung. 66 56-57, 2019.
  13. Kovács, R., Jakab, Á., Tóth, Z., Nagy, F., Emri, T., Pócsi, I., Majoros, L.: Transcriptional and physiological effect exerted by tyrosol on Candida parapsilosis cells.
    J. Fungi. 5 (95), 142-143, 2019.
  14. Tóth, H., Fésüs, A., Kungler-Gorácz, O., Balázs, B., Majoros, L., Szarka, K., Kardos, G.: Utilization of vector autoregressive and linear transfer models to follow up the antibiotic resistance spiral in Gram-negative bacteria from cephalosporin consumption to colistin resistance.
    Clin. Infect. Dis. 69 (8), 1410-1421, 2019.
    Folyóirat-mutatók:
    D1 Infectious Diseases
    D1 Microbiology (medical)
2018
  1. Tóth, Z., Kardos, T., Kovács, R., Kardos, G., Nagy, F., Prépost, E., Barta, Z., Takács, I., Majoros, L.: Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
    Mycopathologia. 183 (6), 905-912, 2018.
    Folyóirat-mutatók:
    Q2 Agronomy and Crop Science
    Q2 Applied Microbiology and Biotechnology
    Q3 Microbiology
    Q2 Plant Science
    Q1 Veterinary (miscellaneous)
  2. Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Majoros, L., Kovács, R.: In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.
    Med. Mycol. 56 (4), 493-500, 2018.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    D1 Veterinary (miscellaneous)
  3. Kardos, T., Kovács, R., Kardos, G., Varga, I., Bozó, A., Tóth, Z., Nagy, F., Majoros, L.: Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
    J. Chemother. 30 (4), 233-239, 2018.
    Folyóirat-mutatók:
    Q3 Infectious Diseases
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q3 Pharmacology
    Q3 Pharmacology (medical)
  4. Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Majoros, L.: The effect of human serum on the efficacy of traditional antifungals against Candida albicans and Candida parapsilosis biofilms.
    Med. Mycol. 56 S131, 2018.
  5. Jakab, Á., Nagy, F., Tóth, Z., Nemes, D., Majoros, L., Bácskay, I., Pócsi, I., Kovács, R.: Tyrosol influences the physiology and virulence of Candida parapsilosis.
    In: Fiatal Biotechnológusok Országos Konferenciája. Szerk.: Tamás László, Zelenyánszki Helga, JATEPress, Szeged, 95, 2018. ISBN: 9789633153703
2017
  1. Kovács, R., Tóth, Z., Nagy, F., Daróczi, L., Bozó, A., Majoros, L.: Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.
    J. Appl. Microbiol. 122 (6), 1529-1536, 2017.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology
    Q2 Biotechnology
    Q2 Medicine (miscellaneous)
  2. Boros, E., Pfliegler, V., Kovács, R., Jakab, Á., Majoros, L., Barta, Z., Pócsi, I.: Candida albicans isolates from a single hospital show low phenotypical specialization.
    J. Basic Microbiol. 57 (11), 910-921, 2017.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology
    Q2 Medicine (miscellaneous)
  3. Pfliegler, V., Boros, E., Pázmándi, K., Jakab, Á., Zsuga, I., Kovács, R., Urbán, E., Antunovics, Z., Bácsi, A., Sipiczki, M., Majoros, L., Pócsi, I.: Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.
    Mol. Nutr. Food Res. 61 (11), 1601099-1 - 1601099-8, 2017.
    Folyóirat-mutatók:
    Q1 Biotechnology
    D1 Food Science
  4. Saleh, Q., Kovács, R., Kardos, G., Gesztelyi, R., Kardos, T., Bozó, A., Majoros, L.: Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.
    Microb. Drug Resist. 23 (6), 764-770, 2017.
    Folyóirat-mutatók:
    Q3 Immunology
    Q1 Medicine (miscellaneous)
    Q2 Microbiology
    Q2 Microbiology (medical)
    Q2 Pharmacology
  5. Kovács, R., Saleh, Q., Bozó, A., Tóth, Z., Gesztelyi, R., Kardos, T., Kardos, G., Takács, I., Majoros, L.: Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
    Mycopathologia. 182 (11-12), 979-987, 2017.
    Folyóirat-mutatók:
    Q2 Agronomy and Crop Science
    Q2 Applied Microbiology and Biotechnology
    Q3 Microbiology
    Q2 Plant Science
    Q2 Veterinary (miscellaneous)
  6. Kardos, T., Saleh, Q., Kovács, R., Gesztelyi, R., Kardos, G., Bozó, A., Tóth, Z., Majoros, L.: Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
    New Microbiol. 40 (4), 286-288, 2017.
    Folyóirat-mutatók:
    Q2 Medicine (miscellaneous)
    Q2 Microbiology (medical)
  7. Kovács, R., Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Kardos, G., Majoros, L.: The in vitro susceptibility pattern of C. kefyr planktonic cells and biofilms against traditional antifungal agents.
    Acta Microbiol. Immunol. Hung. 62 152, 2017.
2016
  1. Ebrahimi, F., Mózes, J., Mészáros, J., Juhász, Á., Majoros, L., Szarka, K., Kardos, G.: Asymptomatic faecal carriage of ESBL producing Enterobacteriaceae in Hungarian healthy individuals and in long-term care applicants: a shift towards CTX-M producers in the community.
    Infect. Dis. 48 (7), 557-559, 2016.
    Folyóirat-mutatók:
    Q3 Immunology and Microbiology (miscellaneous)
    Q2 Infectious Diseases
    Q2 Medicine (miscellaneous)
    Q2 Microbiology (medical)
  2. Ebrahimi, F., Mózes, J., Monostori, J., Kungler-Gorácz, O., Fésüs, A., Majoros, L., Szarka, K., Kardos, G.: Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
    Microbiol. Immunol. 60 (5), 285-294, 2016.
    Folyóirat-mutatók:
    Q3 Immunology
    Q3 Microbiology
    Q3 Virology
  3. Kovács, R., Bozó, A., Gesztelyi, R., Domán, M., Kardos, G., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
    Int. J. Antimicrob. Agents. 47 (4), 304-310, 2016.
    Folyóirat-mutatók:
    Q1 Infectious Diseases
    D1 Medicine (miscellaneous)
    Q1 Microbiology (medical)
    D1 Pharmacology (medical)
  4. Jakab, Á., Antal, K., Emri, T., Boczonádi, I., Imre, A., Gebri, E., Majoros, L., Pfliegler, V., Szarka, M., Balla, G., Balla, J., Pócsi, I.: Effects of hemin, CO2, and pH on the branching of Candida albicans filamentous forms.
    Acta Microbiol. Immunol. Hung. 63 (4), 387-403, 2016.
    Folyóirat-mutatók:
    Q4 Immunology and Microbiology (miscellaneous)
    Q3 Medicine (miscellaneous)
  5. Domán, M., Kovács, R., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Kardos, T., Saleh, Q., Majoros, L.: Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model.
    Current Drug Del. 13 (2), 255-264, 2016.
    Folyóirat-mutatók:
    Q2 Pharmaceutical Science
  6. Bozó, A., Domán, M., Majoros, L., Kardos, G., Varga, I., Kovács, R.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    J. Microbiol. 54 (11), 753-760, 2016.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology
    Q2 Medicine (miscellaneous)
    Q3 Microbiology
  7. Kovács, R., Bozó, A., Nagy, F., Tóth, Z., Majoros, L.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Acta Microbiol. Immunol. Hung. 64 16, 2016.
2015
  1. Jakab, Á., Emri, T., Sipos, L., Kiss, Á., Kovács, R., Dombrádi, V., Kemény-Beke, Á., Balla, J., Majoros, L., Pócsi, I.: Betamethasone augments the antifungal effect of menadione-towards a novel anti-combination therapy.
    J. Basic Microbiol. 55 (8), 973-981, 2015.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology
    Q2 Medicine (miscellaneous)
  2. Domán, M., Kovács, R., Perlin, D., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Majoros, L.: Dose escalation studies with caspofungin against Candida glabrata.
    J. Med. Microbiol. 64 (9), 998-1007, 2015.
    Folyóirat-mutatók:
    Q1 Medicine (miscellaneous)
    Q2 Microbiology
    Q2 Microbiology (medical)
  3. Kovács, R., Bozó, A., Domán, M., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
    Mycoses. 58 79-80, 2015.
2014
  1. Mózes, J., Szűcs, I., Molnár, D., Jakab, P., Fatemeh, E., Szilasi, M., Majoros, L., Orosi, P., Kardos, G.: A potential role of aminoglycoside resistance in endemic occurrence of Pseudomonas aeruginosa strains in lower airways of mechanically ventilated patients.
    Diagn. Microbiol. Infect. Dis. 78 (1), 79-84, 2014.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    Q2 Microbiology (medical)
  2. Berényi, R., Kovács, R., Domán, M., Gesztelyi, R., Kardos, G., Juhász, B., Perlin, D., Majoros, L.: Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
    New Microbiol. 37 (3), 355-362, 2014.
    Folyóirat-mutatók:
    Q2 Medicine (miscellaneous)
    Q2 Microbiology (medical)
  3. Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
    J. Med. Microbiol. 63 (2), 186-194, 2014.
    Folyóirat-mutatók:
    Q1 Medicine (miscellaneous)
    Q2 Microbiology
    Q2 Microbiology (medical)
  4. Kovács, R., Gesztelyi, R., Perlin, D., Kardos, G., Domán, M., Berényi, R., Majoros, L.: Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.
    Mycopathologia. 178 (3-4), 197-206, 2014.
    Folyóirat-mutatók:
    Q2 Agronomy and Crop Science
    Q2 Applied Microbiology and Biotechnology
    Q3 Microbiology
    Q2 Plant Science
    Q1 Veterinary (miscellaneous)
  5. Kovács, R., Czudar, A., Horváth, L., Szakács, L., Majoros, L., Kónya, J.: Serum interleukin-6 levels in murine models of Candida albicans infection.
    Acta Microbiol. Immunol. Hung. 61 (1), 61-69, 2014.
    Folyóirat-mutatók:
    Q4 Immunology and Microbiology (miscellaneous)
    Q3 Medicine (miscellaneous)
  6. Szabó, B., Majoros, L., Pappné Falusi, E., Szabó, Z., Szabó, J., Márton, I., Kelentey, B.: Studies on the possible aetiological role of different Candida species in pathogenesis of dentine caries by monitoring the calcium release from tooth particles.
    Acta Microbiol Immunol Hung. 61 (1), 11-17, 2014.
    Folyóirat-mutatók:
    Q4 Immunology and Microbiology (miscellaneous)
    Q3 Medicine (miscellaneous)
2013
  1. Emri, T., Majoros, L., Tóth, V., Pócsi, I.: Echinocandins: production and applications.
    Appl. Microbiol. Biotechnol. 97 (8), 3267-3284, 2013.
    Folyóirat-mutatók:
    Q1 Applied Microbiology and Biotechnology
    Q1 Biotechnology
    D1 Medicine (miscellaneous)
  2. Majoros, L., Kovács, R., Berényi, R., Domán, M., Miszti, C., Kardos, G.: Effect of 50% human serum on he killing activity of micafungin against C. dubliniensis, C. lusitaniae, C. guilliermondii and C. kefyr using time-kill methodology.
    Mycoses. 56 64-65, 2013.
  3. Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Should echinocandin doses be increased against Candida species? An in vitro and in vivo study of caspofungin against Candida albicans, C. krusei and C. inconspicua.
    Mycoses. 56 (Suppl.), 60, 2013.
2012
  1. Antal-Szalmás, P., Vida, A., Majoros, L., Sümegi, A., Bácsi, A., Vereb, G., Strijp, J., Kessel, K.: CD14/Fc fusion protein - an artificial antibody.
    Cytometry B Clin. Cytom. 82 410, 2012.
  2. Földi, R., Kovács, R., Gesztelyi, R., Kardos, G., Berényi, R., Juhász, B., Szilágyi, J., Mózes, J., Majoros, L.: Comparison of In Vitro and Vivo Efficacy of Caspofungin Against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans.
    Mycopathologia. 174 (4), 311-318, 2012.
    Folyóirat-mutatók:
    Q2 Agronomy and Crop Science
    Q2 Applied Microbiology and Biotechnology
    Q3 Microbiology
    Q2 Plant Science
    Q2 Veterinary (miscellaneous)
  3. Szilágyi, J., Földi, R., Gesztelyi, R., Bayegan, S., Kardos, G., Juhász, B., Majoros, L.: Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
    Chemotherapy. 58 (2), 159-164, 2012.
    Folyóirat-mutatók:
    Q2 Drug Discovery
    Q2 Infectious Diseases
    Q2 Medicine (miscellaneous)
    Q2 Oncology
    Q2 Pharmacology
    Q2 Pharmacology (medical)
  4. Földi, R., Szilágyi, J., Kardos, G., Berényi, R., Kovács, R., Majoros, L.: Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
    Diagn. Microbiol. Infect. Dis. 73 (4), 338-342, 2012.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    Q2 Microbiology (medical)
  5. Szilágyi, J., Földi, R., Sedigh, B., Kardos, G., Majoros, L.: Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology.
    J. Chemother. 24 (1), 18-25, 2012.
    Folyóirat-mutatók:
    Q3 Infectious Diseases
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q3 Pharmacology
    Q2 Pharmacology (medical)
  6. Vida, A., Bardoel, B., Milder, F., Majoros, L., Sümegi, A., Bácsi, A., Vereb, G., Kessel, K., Strijp, J., Antal-Szalmás, P.: Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils.
    Immunol. Lett. 146 (1-2), 31-39, 2012.
    Folyóirat-mutatók:
    Q2 Immunology
    Q2 Immunology and Allergy
  7. Ádám, C., Erdei, É., Casado, C., Kovács, L., Gonzalez, A., Majoros, L., Petrényi, K., Bagossi, P., Farkas, I., Molnár, M., Pócsi, I., Ariño, J., Dombrádi, V.: Protein phosphatase CaPpz1 is involved in cation homeostasis, cell wall integrity and virulence of Candida albicans.
    Microbiology (Reading, Engl.). 158 (5), 1258-1267, 2012.
    Folyóirat-mutatók:
    Q1 Microbiology
2011
  1. Bayegan, S., Szilágyi, J., Kemény-Beke, Á., Földi, R., Kardos, G., Gesztelyi, R., Juhász, B., Adnan, A., Majoros, L.: Efficacy of a single 6 mg/kg versus two 3 mg/kg caspofungin doses for treatment of disseminated candidiasis caused by Candida albicans in a neutropenic mouse model.
    J. Chemother. 23 (2), 107-109, 2011.
    Folyóirat-mutatók:
    Q3 Infectious Diseases
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q3 Pharmacology
    Q2 Pharmacology (medical)
2010
  1. Fejes, Z., Mándi, A., Komáromi, I., Majoros, L., Batta, G., Herczegh, P.: A synthetic and in silico study on the highly regioselective Diels-Alder reaction of the polyenic antifungal antibiotics natamycin and flavofungin.
    Tetrahedron Lett. 51 (38), 4968-4971, 2010.
    Folyóirat-mutatók:
    Q2 Biochemistry
    Q1 Drug Discovery
    Q1 Organic Chemistry
  2. Grenczer, M., Zsuga, J., Majoros, L., Pintér, Á., Kemény-Beke, Á., Juhász, B., Tósaki, Á., Gesztelyi, R.: Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
    Can. J. Physiol. Pharmacol. 88 (11), 1074-1083, 2010.
    Folyóirat-mutatók:
    Q2 Medicine (miscellaneous)
    Q2 Pharmacology
    Q3 Physiology
    Q2 Physiology (medical)
  3. Tavanti, A., Hensgens, L., Mogavero, S., Majoros, L., Senesi, S., Campa, M.: Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites.
    BMC Microbiol. 10 203, 2010.
    Folyóirat-mutatók:
    Q1 Microbiology
    Q1 Microbiology (medical)
  4. Szabó, Z., Borbély, Á., Kardos, G., Somogyvári, F., Kemény-Beke, Á., Asztalos, L., Rozgonyi, F., Majoros, L.: In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-kill methodology.
    Mycoses. 53 (3), 196-199, 2010.
    Folyóirat-mutatók:
    Q2 Dermatology
    Q2 Infectious Diseases
    Q2 Medicine (miscellaneous)
  5. Bayegan, S., Majoros, L., Kardos, G., Kemény-Beke, Á., Miszti, C., Kovács, R., Gesztelyi, R.: In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin.
    J. Microbiol. 48 (2), 170-173, 2010.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology
    Q2 Medicine (miscellaneous)
    Q3 Microbiology
  6. Kovács, L., Farkas, I., Majoros, L., Miskei, M., Pócsi, I., Dombrádi, V.: The polymorphism of protein phosphatase Z1 gene in Candida albicans.
    J. Basic Microbiol. 50 (Suppl.), S74-S82, 2010.
    Folyóirat-mutatók:
    Q2 Applied Microbiology and Biotechnology
    Q2 Medicine (miscellaneous)
2009
  1. Varga, I., Sóczó, G., Kardos, G., Kemény-Beke, Á., Kelentey, B., Márton, I., Majoros, L.: Differences in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
    J. Chemother. 21 (1), 36-41, 2009.
    Folyóirat-mutatók:
    Q3 Infectious Diseases
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q3 Pharmacology
    Q2 Pharmacology (medical)
  2. Szabó, Z., Szilágyi, J., Tavanti, A., Kardos, G., Rozgonyi, F., Bayegan, S., Majoros, L.: In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.
    Diagn. Microbiol. Infect. Dis. 64 (3), 283-288, 2009.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    Q1 Microbiology (medical)
2008
  1. Varga, I., Sóczó, G., Kardos, G., Borbély, Á., Szabó, Z., Kemény-Beke, Á., Majoros, L.: Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis.
    J. Antimicrob. Chemother. 62 (6), 1466-1468, 2008.
    Folyóirat-mutatók:
    D1 Infectious Diseases
    D1 Pharmacology
    D1 Pharmacology (medical)
  2. Szabó, Z., Lajszné Tóth, B., Kovács, M., Kardos, G., Maráz, A., Rozgonyi, F., Majoros, L.: Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification.
    J. Clin. Microbiol. 46 (5), 1824-1825, 2008.
    Folyóirat-mutatók:
    D1 Microbiology (medical)
  3. Majoros, L., Kardos, G.: Fungicidal activity of azole antifungal agents.
    Anti-Infect. Agents Med. Chem. 7 (2), 118-125, 2008.
  4. Fekete, A., Pócsi, I., Emri, T., Gyetvai, Á., Gazdag, Z., Pesti, M., Karányi, Z., Majoros, L., Gergely, L., Pócsi, I.: Physiological and morphological characterization of tert-butylhydroperoxide tolerant Candida albicans mutants.
    J. Basic Microbiol. 48 (6), 480-487, 2008.
    Folyóirat-mutatók:
    Q3 Applied Microbiology and Biotechnology
    Q2 Medicine (miscellaneous)
  5. Varga, I., Sóczó, G., Kardos, G., Majoros, L.: Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3.
    J. Antimicrob. Chemother. 62 (1), 149-152, 2008.
    Folyóirat-mutatók:
    D1 Infectious Diseases
    D1 Pharmacology
    D1 Pharmacology (medical)
2007
  1. Sóczó, G., Kardos, G., McNicholas, P., Balogh, É., Gergely, L., Varga, I., Kelentey, B., Majoros, L.: Correlation of posaconazole minimum fungicidal concentration and time-kill test against nine Candida species.
    J. Antimicrob. Chemother. 60 (5), 1004-1009, 2007.
    Folyóirat-mutatók:
    Q1 Infectious Diseases
    Q1 Pharmacology
    D1 Pharmacology (medical)
  2. Sóczó, G., Kardos, G., Varga, I., Kelentey, B., Gesztelyi, R., Majoros, L.: In vitro study of candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin.
    Antimicrob. Agents Chemother. 51 (12), 4474-4476, 2007.
    Folyóirat-mutatók:
    D1 Infectious Diseases
    D1 Pharmacology
    D1 Pharmacology (medical)
  3. Sóczó, G., Kardos, G., McNicholas, P., Falusi, E., Gergely, L., Majoros, L.: Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
    Mycoses. 50 (3), 178-182, 2007.
    Folyóirat-mutatók:
    Q2 Dermatology
    Q3 Infectious Diseases
    Q2 Medicine (miscellaneous)
2006
  1. Alberth, M., Majoros, L., Kovalecz, G., Borbás, E., Szegedi, I., Márton, I., Kiss, C.: Significance of oral Candida infections in children with cancer.
    Pathol. Oncol. Res. 12 (4), 237-241, 2006.
    Folyóirat-mutatók:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q2 Oncology
    Q2 Pathology and Forensic Medicine
  2. Majoros, L., Szegedi, I., Kardos, G., Erdész, C., Kónya, J., Kiss, C.: Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study.
    Eur. J. Clin. Microbiol. Infect. Dis. 25 (12), 803-806, 2006.
    Folyóirat-mutatók:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    Q2 Microbiology (medical)
2005
  1. Majoros, L., Kardos, G., Szabó, G., Sipiczki, M.: Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal fungicidal concentration.
    Antimicrob. Agents Chemother. 49 (8), 3486-3488, 2005.
    Folyóirat-mutatók:
    D1 Infectious Diseases
    D1 Pharmacology
    D1 Pharmacology (medical)
  2. Majoros, L., Kardos, G., Feiszt, P., Szabó, B.: Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
    J. Antimicrob. Chemother. 56 (1), 253-254, 2005.
    Folyóirat-mutatók:
    Q1 Infectious Diseases
    D1 Pharmacology
    D1 Pharmacology (medical)
  3. Majoros, L., Kardos, G., Szabó, B., Kovács, M., Maráz, A.: Fluconazole susceptibility testing of Candida inconspicua clinical isolates: comparison of four methods.
    J. Antimicrob. Chemother. 55 (2), 275-276, 2005.
    Folyóirat-mutatók:
    Q1 Infectious Diseases
    D1 Pharmacology
    D1 Pharmacology (medical)
  4. Farkas, I., Ádám, C., Molnár, G., Kovács, L., Majoros, L., Aradi, J., Dombrádi, V.: Molecular characterization of the PPZ1 gene from Candida albicans.
    FEBS J. 272 (Suppl1), 511, 2005.
2004
  1. Sugita, T., Takeo, K., Ohkusu, M., Virtudazo, E., Takashima, M., Asako, E., Ohshima, F., Harada, C., Nishikawa, A., Majoros, L., Sipiczki, M.: Fluconazole-resistant pathogens Candida inconspicus and C. norvegicus: DNA sequence diversity of the rRNA intergenic spacer region, antifungal drug susceptibility and extracellular enzyme production.
    Microbiol. Immunol. 48 761-766, 2004.
  2. Barta, Z., Csípő, I., Mekkel, G., Zeher, M., Majoros, L., Bernstein, C., Collins, M.: Seroprevalence of Mycobacterium paratuberculosis in Patients with Crohn's Disease.
    J. Clin. Microbiol. 42 (11), 5432-5433, 2004.
    Folyóirat-mutatók:
    D1 Microbiology (medical)
2003
  1. Majoros, L., Kardos, G., Belak, A., Maráz, A., Asztalos, L., Csánky, E., Barta, Z., Szabó, B.: Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional Diagnostic Procedures.
    J. Clin. Microbiol. 41 (11), 5250-5253, 2003.
    Folyóirat-mutatók:
    D1 Microbiology (medical)
2002
  1. Majoros, L., Kardos, G., Pócsi, I., Szabó, B.: Distribution and susceptibility of Candida species isolated in the Medical University of Debrecen.
    Acta Microbiol. Immunol. Hung. 49 (2-3), 351-361, 2002.
    Folyóirat-mutatók:
    Q4 Immunology and Microbiology (miscellaneous)
    Q3 Medicine (miscellaneous)
2001
  1. Pócsi, I., Sámi, L., Leiter, É., Majoros, L., Szabó, B., Emri, T., Pusztahelyi, T.: Searching for new-type antifungal drugs.
    Acta Microbiol Immunol Hung. 48 (3), 533-543, 2001.
    Folyóirat-mutatók:
    Q4 Immunology and Microbiology (miscellaneous)
    Q3 Medicine (miscellaneous)
feltöltött közlemény: 115 Open Access: 50
https://tudoster.idea.unideb.hu
A szolgáltatást nyújtja: DEENK